{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-028937","form_type":"8-K","ticker":"PBYI","cik":"0001401667","company_name":"PUMA BIOTECHNOLOGY, INC.","filed_at":"2022-12-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.462080+00:00","generated_at":"2026-06-21T05:16:49.056060+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Puma Biotechnology sells $2.5M of common stock to CEO Alan Auerbach in private placement","bullets":["Sold 568,181 shares of common stock to CEO Alan Auerbach at $4.40/share, gross proceeds ~$2.5M.","Purchase price equaled December 9, 2022 closing price; private placement closed December 12, 2022.","Shares issued under Section 4(a)(2) exemption, not registered under Securities Act.","Proceeds for general corporate purposes; no specific use disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-028937","json":"https://secwatch.observer/filing/0001437749-22-028937.json","markdown":"https://secwatch.observer/filing/0001437749-22-028937.md","text":"https://secwatch.observer/filing/0001437749-22-028937.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922028937/0001437749-22-028937-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922028937/pbyi20221212_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T05:16:49.056060+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"71bff2ce6c1f92f8a12ee9ebde5604847a8c9717","claim":"PUMA BIOTECHNOLOGY, INC. entered into Securities Purchase Agreement with Alan H. Auerbach valued at approximately $2.5 million (effective 2022-12-09).","evidence_excerpt":"On December 9, 2022, Puma Biotechnology, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with Alan H. Auerbach, the Company’s President, Chief Executive Officer and Chairman of the Board (the “Purchaser”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922028937/0001437749-22-028937-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"Alan H. Auerbach"},{"label":"Value","value":"approximately $2.5 million"},{"label":"Effective","value":"2022-12-09"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}